Filing status
- Accounts due
- 30 June 2026
- Last accounts
- 30 June 2024
- Conf. stmt due
- 3 November 2026
- Last conf. stmt
- 20 October 2025
Cantabio Pharmaceuticals Ltd
- Incorporated
- 21 October 2020 (6 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Accounts type
- Total exemption full
- Region
- North West
- Address
- St. George's CourtWinnington AvenueNorthwichCW8 4EE
Officers
Not loaded yet. See them on Companies House
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Financials
Balance sheet as at 30 June 2024 · total exemption full accounts
- Cash
- £12,432
- Current Ratio
- 0.5x
Trend
Shareholder Funds
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Fixed Assets | £7,658 | £6,836 | ||
| Current Assets | £562,390 | £253,425 | £6,946 | £40,983 |
| Debtors | £549,958 | £244,705 | £0 | £31,579 |
| Cash | £12,432 | £8,720 | £6,946 | £9,404 |
| Creditors (< 1 year) | £1,041,811 | £610,287 | £244,685 | £132,181 |
| Net Current Assets | (£479,421) | (£356,862) | (£237,739) | (£91,198) |
| Shareholder Funds | (£471,763) | (£350,026) | (£237,739) | (£91,198) |
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →